IL-10 in HIV infection: Increasing serum IL-10 levels with disease progression-down-regulatory effect of potent anti-retroviral therapy

Clinical and Experimental Immunology

Volumn 116, Issue 1, 1999, Pages 115-120

  Stylianou, Eva ^a   Aukrust, P ^a   Kvale, D ^a   Muller F ^a   FrOland S S ^a  

^a Research Institute for Internal Medicine   (Norway)

Author keywords

Anti retroviral therapy; HIV infection; IL 10; Mycobacterium avium complex; Tumour necrosis factor alpha

Indexed keywords

ANTIRETROVIRUS AGENT; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; PRIORITY JOURNAL;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; CROSS-SECTIONAL STUDIES; CYTOMEGALOVIRUS RETINITIS; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; INTERLEUKIN-10; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; PNEUMONIA, PNEUMOCYSTIS; REVERSE TRANSCRIPTASE INHIBITORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032955893     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00865.x     Document Type: Article

References (40)

1. 1 Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170:2081-5.
2. 2 Benjamin D, Knobloch TJ, Dayton MA. Human B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitts lymphoma constitutively secrete large quantities of interleukin-10. Blood 1992; 80:1289-98.
3. 3 Burdin N, Peronne C, Banchereau J, Rousset F. Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10. J Exp Med 1993; 177:295-304.
4. 4 Moore KWO, Garra A, de Waal Malefyt R, Vieira R, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993; 11:165-9.
5. 5 Mosmann TR. Properties and functions of interleukin-10. Adv Immunol 1994; 56:1-26.
6. 6 de Waal Malefyt R, Haanen J, Spits H et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduced antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class major histocompatibility complex expression. J Exp Med 1991; 174:915-24.
7. 7 Fiorentino DF, Zlotnic A, Viera P et al. IL-10 acts on the antigen presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991; 146:3444-51.
8. 8 Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphocytokine activities and secreted proteins. J Immunol 1986; 136:2348-57.
9. 9 Del Prete GF, De Carli M, Maustromaro C et al. Purified protein derivative of Mycobacterium tuberculosis and excretory/secretory antigen(s) of Toxocara canis expand in vitro T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest 1991; 88:346-50.
10. 10 Romagnani S. Biology of human Th1 and Th2 cells. J Clin Immunol 1995; 15:121-9.
11. 11 Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383:787-93.
12. 12 Clerici M, Shearer GM. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 1994; 15:575-81.
13. 13 Barcellini W, Rizzardi GP, Borghi MO, Fain C, Lazzarin A, Meroni PL. Th1 and Th2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients. AIDS 1994; 8:757-62.
14. 14 Clerici M, Wynn TA, Berzofsky JA et al. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J Clin Invest 1994; 93:768-75.
15. 15 Jason J, Sleeper LA, Donfield SM et al. Evidence for a shift from a type 1 lymphocyte pattern with HIV disease progression. J AIDS Hum Retrovir 1995; 10:471-6.
16. 16 Meroni L, Trabattoni D, Balotta C et al. Evidence for type 2 cytokine production and lymphocyte activation in the early phases of HIV-1 infection. AIDS 1996; 10:23-30.
17. 17 Romagnani S, Maggi E, del Prete G. An alternative view of the Th1/Th2 switch hypothesis in HIV infection. AIDS Res Hum Retrovir 1994; 10:3-9.
18. 18 Maggi E, Mazztti M, Ravina A et al. Ability of HIV to promote a Th1 to Th2 shift and to replicate preferentially in Th2 and Th0 cells. Science 1994; 265:244-8.
19. 19 Graziosi C, Pantaleo G, Gantt KR et al. Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected patients. Sci 1994; 265:248-52.
20. 20 Daftarian MP, Diaz-Mitoma F, Creery WD, Cameron W, Kumar A. Dysregulated production of interleukin-10 (IL-10) and IL-12 by peripheral blood lymphocytes from human immunodeficiency virus-infected individuals is associated with altered proliferative responses to recall antigens. Clin Diagn Lab Immunol 1995; 2:712-8.
21. 21 Akridge RE, Oyafuso LKM, Reed SG. IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J Immunol 1994; 153:5782-9.
22. 22 Diaz-Mitoma F, Kumar A, Karimi S et al. Expression of IL-10, IL-4 and interferon-gamma in unstimulated and mitogen-stimulated peripheral blood lymphocytes from HIV-seropositive patients. Clin Exp Immunol 1995; 102:31-39.
23. 23 Taga K, Cherney B, Tosato G. IL-10 inhibits apoptotic cell death in human T cells starved of IL-2. Int Immunol 1993; 5:1599-608.
24. 24 Weissman DP, Poli G, Fauci AS. Interleukin 10 blocs HIV replication in macrophages by inhibiting the autocrine loop of TNF-α and IL-6 induction of virus. AIDS Res Hum Retrovir 1994; 10:1199-206.
25. 25 Weissman D, Poli G, Fauci AS. IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocytic lineage. J AIDS Hum Retrovir 1995; 9:442-9.
26. 26 Centers for Disease Control and Prevention. 1993 revised classification for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992; 41:1-19.
27. 27 Aukrust P, Liabakk NB, Muller F, Lien E, Espevik T, Frøland SS. Serum levels of tumor necrosis factor-α (TNF-α) and soluble TNF receptors in human immunodeficiency virus type 1 infection - correlations to clinical, immunologic, and virologic parameters. J Infect Dis 1994; 169:420-4.
28. 28 Brinchman JE, Vartal F, Gaudernak G et al. Direct immunomagnetic quantification of lymphocyte subsets in blood. Clin Exp Immunol 1988; 71:182-6.
29. 29 van der Poll T, Jansen J, Levi M, ten Cate H, ten Cate JW, van Deventer SJH. Regulation of interleukin 10 release by tumor necrosis factor in human and chimpanzees. J Exp Med 1994; 180:1985-8.
30. 30 Fauci AS. Host factors and the pathogenesis of HIV-induced disease. Nature 1996; 384:529-34.
31. 31 Aukrust P, Muller F, Lien E et al. Tumor necrosis factor (TNF) system in HIV-infected patients during highly active antiretroviral therapy (HAART)-persistent TNF activation is associated with virologic and imunologic treatment failure. J Infect Dis, 1999; 179:74-82.
32. 32 Taaoufik Y, Lantz O, Wallon C, Charles A, Dussaix E, Delfraissy JF. Human immunodeficiency virus gp120 inhibits interleukin-12 secretion by human monocytes: an indirect interleukin-10-mediated effect. Blood 1997; 89:2842-8.
33. 33 Benson CA, Ellner JJ. Mycobacterium-avium complex infection and AIDS - advances in theory and practice. Clin Infect Dis 1993; 17:7-20.
34. 34 Muller F, Aukrust P, Lien E, Haug CJ, Espevik T, Frøland SS. Enhanced interleukin-10 production in response to Mycobacterium avium products in mononuclear cells from patients with human immunodeficiency virus infection. J Infect Dis 1998; 177:586-94.
35. 35 Ghassemi M, Andersen BR, Reddy VM, Gangadharam PR, Spear GT, Novak RM. Human immunodeficiency virus and Mycobacterium avium complex coinfection of monocytoid cells results in reciprocal enhancement of multiplication. J Infect Dis 1995; 171:68-73.
36. 36 Haug CJ, Aukrust P, Lien E, Muller F, Espevik T, Frøland S. Disseminated Mycobacterium avium complex infection in AIDS: significance of an activated tumor necrosis factor system and depressed serum levels of 1,25 dihydroxyvitamin D. J Inf Dis 1995; 173:259-62.
37. 37 Miedema F, Petit AJ, Terpstra FG et al. Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. J Clin Invest 1988, 82:1908-16.
38. 38 Georgescu L, Vakkalanka RK, Elkon KB, Crow MK. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand. J Clin Invest 1997; 100:2622-33.
39. 39 Kelleher AD, Carr A, Zaunders J, Cooper DA. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J Infect Dis 1996; 173:321-9.
40. 40 Cameron WD, Heath-Chiozzi M, Danner S et al. Randomised placebo-controlled trial of ritonavir in advanced HIV-disease. Lancet 1998; 351:543-9.